Kawasumi H - Search Results

1

Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis.

Kochi Y, Kamatani Y, Kondo Y, Suzuki A, Kawakami E, Hiwa R, Momozawa Y, Fujimoto M, Jinnin M, Tanaka Y, Kanda T, Cooper RG, Chinoy H, Rothwell S, Lamb JA, Vencovský J, Mann H, Ohmura K, Myouzen K, Ishigaki K, Nakashima R, Hosono Y, Tsuboi H, Kawasumi H, Iwasaki Y, Kajiyama H, Horita T, Ogawa-Momohara M, Takamura A, Tsunoda S, Shimizu J, Fujio K, Amano H, Mimori A, Kawakami A, Umehara H, Takeuchi T, Sano H, Muro Y, Atsumi T, Mimura T, Kawaguchi Y, Mimori T, Takahashi A, Kubo M, Kohsaka H, Sumida T, Yamamoto K. Kochi Y, et al. Among authors: kawasumi h. Ann Rheum Dis. 2018 Apr;77(4):602-611. doi: 10.1136/annrheumdis-2017-212149. Epub 2018 Jan 13. Ann Rheum Dis. 2018. PMID: 29331962

2

Association of Serum Soluble CD163 with Polymyositis and Dermatomyositis, Especially in Anti-MDA5 Antibody-positive Cases.

Kawasumi H, Katsumata Y, Nishino A, Hirahara S, Kawaguchi Y, Kuwana M, Yamanaka H. Kawasumi H, et al. J Rheumatol. 2018 Jul;45(7):947-955. doi: 10.3899/jrheum.170997. Epub 2018 Apr 15. J Rheumatol. 2018. PMID: 29657141

3

KL-6 is a long-term disease-activity biomarker for interstitial lung disease associated with polymyositis/dermatomyositis, but is not a short-term disease-activity biomarker.

Hanaoka M, Katsumata Y, Kawasumi H, Kawaguchi Y, Yamanaka H. Hanaoka M, et al. Among authors: kawasumi h. Mod Rheumatol. 2019 Jul;29(4):625-632. doi: 10.1080/14397595.2018.1553488. Epub 2019 Jan 8. Mod Rheumatol. 2019. PMID: 30484723

4

Clinical Manifestations and Myositis-Specific Autoantibodies Associated with Physical Dysfunction after Treatment in Polymyositis and Dermatomyositis: An Observational Study of Physical Dysfunction with Myositis in Japan.

Kawasumi H, Gono T, Kawaguchi Y, Kuwana M, Kaneko H, Katsumata Y, Kataoka S, Hanaoka M, Yamanaka H. Kawasumi H, et al. Biomed Res Int. 2016;2016:9163201. doi: 10.1155/2016/9163201. Epub 2016 Jan 26. Biomed Res Int. 2016. PMID: 26925419 Free PMC article.

5

Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies.

Kawasumi H, Gono T, Kawaguchi Y, Yamanaka H. Kawasumi H, et al. Clin Med Insights Circ Respir Pulm Med. 2015 Jul 23;9(Suppl 1):9-17. doi: 10.4137/CCRPM.S23313. eCollection 2015. Clin Med Insights Circ Respir Pulm Med. 2015. PMID: 26279636 Free PMC article. Review.

6

IL-6, IL-8, and IL-10 are associated with hyperferritinemia in rapidly progressive interstitial lung disease with polymyositis/dermatomyositis.

Kawasumi H, Gono T, Kawaguchi Y, Kaneko H, Katsumata Y, Hanaoka M, Kataoka S, Yamanaka H. Kawasumi H, et al. Biomed Res Int. 2014;2014:815245. doi: 10.1155/2014/815245. Epub 2014 Apr 1. Biomed Res Int. 2014. PMID: 24800252 Free PMC article.

7

Reliability of the SF-36 in Japanese patients with systemic lupus erythematosus and its associations with disease activity and damage: a two-consecutive year prospective study.

Baba S, Katsumata Y, Okamoto Y, Kawaguchi Y, Hanaoka M, Kawasumi H, Yamanaka H. Baba S, et al. Among authors: kawasumi h. Lupus. 2018 Mar;27(3):407-416. doi: 10.1177/0961203317725586. Epub 2017 Aug 10. Lupus. 2018. PMID: 28795653

8

Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus.

Nishino A, Katsumata Y, Kawasumi H, Hirahara S, Kawaguchi Y, Yamanaka H. Nishino A, et al. Among authors: kawasumi h. Lupus. 2019 Jul;28(8):986-994. doi: 10.1177/0961203319860201. Lupus. 2019. PMID: 31246559

9

Clinical manifestations of Adult-onset Still's disease presenting with erosive arthritis: Association with low levels of ferritin and Interleukin-18.

Ichida H, Kawaguchi Y, Sugiura T, Takagi K, Katsumata Y, Gono T, Ota Y, Kataoka S, Kawasumi H, Yamanaka H. Ichida H, et al. Among authors: kawasumi h. Arthritis Care Res (Hoboken). 2014 Apr;66(4):642-6. doi: 10.1002/acr.22194. Arthritis Care Res (Hoboken). 2014. PMID: 24124073 Free article.

10

Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease.

Gono T, Kaneko H, Kawaguchi Y, Hanaoka M, Kataoka S, Kuwana M, Takagi K, Ichida H, Katsumata Y, Ota Y, Kawasumi H, Yamanaka H. Gono T, et al. Among authors: kawasumi h. Rheumatology (Oxford). 2014 Dec;53(12):2196-203. doi: 10.1093/rheumatology/keu258. Epub 2014 Jun 26. Rheumatology (Oxford). 2014. PMID: 24970922

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page